Optics • Semiconductors • Chemicals/Specialty Materials • Alternative Energy • Nanotechnology • Electronics/Instrumentation
Nicholas Darby, Ph.D., joined ARCH as an Executive in Residence in late 2008. Dr. Darby brings considerable expertise in new business development and evaluating and shaping nascent companies for venture investing.
Dr. Darby is a founding member and Director for more than twelve years in the Corporate Venture Capital Group at Dow Chemical, one of the most successful corporate venture groups in the world in capital deployed, profitability and longevity. He was responsible for numerous investments in corporate spin-outs and university-based start-up companies, primarily in the Physical Sciences.
Prior to his work with Dow’s venture group, Dr. Darby was an executive in Dow Chemical Canada’s Research and Development and in Corporate New Business Development. He directed programs in many industries and diverse markets including energy generation, advanced materials and electronics (including displays, data storage, compound semiconductors, organic electronics, and packaging/interconnect).
Dr. Darby received post-doctoral training at the University of British Columbia and was a Fellow at University College, London. He holds a Ph.D. from the University of Alberta, and a B.Sc. with Honors from Queen’s University, Canada.